neridronic acid Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central MeSH PubChem

Active Ingredient History

NOW
  • Now
Neridronic acid is a bisphosphonate. In Italy it is used to treat Osteogenesis imperfecta and Paget's disease of bone.   Wikipedia

Chemistry

  • SMILES: NCCCCCC(O)(P(=O)(O)O)P(=O)(O)O
  • InChIKey: PUUSSSIBPPTKTP-UHFFFAOYSA-N
  • Mol. Mass: 277.15
  • ALogP: -0.49
  • ChEMBL Molecule:
    neridronic acid  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

6-ahhdp | 6-amino-1-hydroxyhexane-1,1-diphosphonate | 6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid | (6-amino-1-hydroxyhexylidene)diphosphonic acid | ahhexbp | aminohexane bisphosphonate | neridronate | neridronic acid

Organizations (9)

Research & Development (9)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

beta-Thalassemia (Phase 2)

Complex Regional Pain Syndromes (Phase 3)

Osteoarthritis, Knee (Phase 2)

Osteoporosis (Phase 2)

Pain (Phase 3)

Reflex Sympathetic Dystrophy (Phase 2/Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial Organizations: 9

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue